These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 14568408)

  • 1. Liposome delivery of ciprofloxacin against intracellular Francisella tularensis infection.
    Wong JP; Yang H; Blasetti KL; Schnell G; Conley J; Schofield LN
    J Control Release; 2003 Oct; 92(3):265-73. PubMed ID: 14568408
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Aerosol delivery of liposome-encapsulated ciprofloxacin: aerosol characterization and efficacy against Francisella tularensis infection in mice.
    Conley J; Yang H; Wilson T; Blasetti K; Di Ninno V; Schnell G; Wong JP
    Antimicrob Agents Chemother; 1997 Jun; 41(6):1288-92. PubMed ID: 9174185
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Liposome encapsulation of ciprofloxacin improves protection against highly virulent Francisella tularensis strain Schu S4.
    Hamblin KA; Armstrong SJ; Barnes KB; Davies C; Wong JP; Blanchard JD; Harding SV; Simpson AJ; Atkins HS
    Antimicrob Agents Chemother; 2014 Jun; 58(6):3053-9. PubMed ID: 24637682
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Liposome-encapsulated ciprofloxacin is effective in the protection and treatment of BALB/c mice against Francisella tularensis.
    Di Ninno VL; Cherwanogrodzky JW; Wong JP
    J Infect Dis; 1993 Sep; 168(3):793-4. PubMed ID: 8354928
    [No Abstract]   [Full Text] [Related]  

  • 5. The potential of liposome-encapsulated ciprofloxacin as a tularemia therapy.
    Hamblin KA; Wong JP; Blanchard JD; Atkins HS
    Front Cell Infect Microbiol; 2014; 4():79. PubMed ID: 24995163
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antibacterial efficacy against an in vivo Salmonella typhimurium infection model and pharmacokinetics of a liposomal ciprofloxacin formulation.
    Webb MS; Boman NL; Wiseman DJ; Saxon D; Sutton K; Wong KF; Logan P; Hope MJ
    Antimicrob Agents Chemother; 1998 Jan; 42(1):45-52. PubMed ID: 9449259
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vivo efficacy of fluoroquinolones against systemic tularaemia infection in mice.
    Piercy T; Steward J; Lever MS; Brooks TJ
    J Antimicrob Chemother; 2005 Dec; 56(6):1069-73. PubMed ID: 16223941
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nanoaerosols reduce required effective dose of liposomal levofloxacin against pulmonary murine Francisella tularensis subsp. novicida infection.
    Propst CN; Nwabueze AO; Kanev IL; Pepin RE; Gutting BW; Morozov VN; van Hoek ML
    J Nanobiotechnology; 2016 Apr; 14():29. PubMed ID: 27090889
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The chemotherapeutic efficacy of ciprofloxacin and lomefloxacin in the inhalation method of infecting white mice with tularemia].
    D'iakov SI; Bubnov VP; Lebedeva IK; Sidorenko SV; Moskalenko VI
    Antibiot Khimioter; 2000; 45(6):17-20. PubMed ID: 10904804
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthetic Macromolecular Antibiotic Platform for Inhalable Therapy against Aerosolized Intracellular Alveolar Infections.
    Das D; Chen J; Srinivasan S; Kelly AM; Lee B; Son HN; Radella F; West TE; Ratner DM; Convertine AJ; Skerrett SJ; Stayton PS
    Mol Pharm; 2017 Jun; 14(6):1988-1997. PubMed ID: 28394614
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The efficacy of ciprofloxacin and doxycycline against experimental tularaemia.
    Russell P; Eley SM; Fulop MJ; Bell DL; Titball RW
    J Antimicrob Chemother; 1998 Apr; 41(4):461-5. PubMed ID: 9598777
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Macrophage-targeted drugamers with enzyme-cleavable linkers deliver high intracellular drug dosing and sustained drug pharmacokinetics against alveolar pulmonary infections.
    Su FY; Srinivasan S; Lee B; Chen J; Convertine AJ; West TE; Ratner DM; Skerrett SJ; Stayton PS
    J Control Release; 2018 Oct; 287():1-11. PubMed ID: 30099019
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oral immunization of mice with the live vaccine strain (LVS) of Francisella tularensis protects mice against respiratory challenge with virulent type A F. tularensis.
    KuoLee R; Harris G; Conlan JW; Chen W
    Vaccine; 2007 May; 25(19):3781-91. PubMed ID: 17346863
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Consequences of delayed ciprofloxacin and doxycycline treatment regimens against Francisella tularensis airway infection.
    Rotem S; Bar-Haim E; Cohen H; Elia U; Ber R; Shafferman A; Cohen O
    Antimicrob Agents Chemother; 2012 Oct; 56(10):5406-8. PubMed ID: 22850512
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Needle-Free Delivery of Acetalated Dextran-Encapsulated AR-12 Protects Mice from Francisella tularensis Lethal Challenge.
    Hoang KV; Curry H; Collier MA; Borteh H; Bachelder EM; Schlesinger LS; Gunn JS; Ainslie KM
    Antimicrob Agents Chemother; 2016 Apr; 60(4):2052-62. PubMed ID: 26787696
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aerosol-, but not intradermal-immunization with the live vaccine strain of Francisella tularensis protects mice against subsequent aerosol challenge with a highly virulent type A strain of the pathogen by an alphabeta T cell- and interferon gamma- dependent mechanism.
    Wayne Conlan J; Shen H; Kuolee R; Zhao X; Chen W
    Vaccine; 2005 Mar; 23(19):2477-85. PubMed ID: 15752834
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of liposome-encapsulated ciprofloxacin on phagocytosis, nitric oxide and intracellular killing of Staphylcoccus aureus by murine macrophages.
    Wong JP; Schnell G; Simpson M; Saravolac E
    Artif Cells Blood Substit Immobil Biotechnol; 2000 Sep; 28(5):415-28. PubMed ID: 11009114
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Fluorocycline TP-271 Is Efficacious in Models of Aerosolized Francisella tularensis SCHU S4 Infection in BALB/c Mice and Cynomolgus Macaques.
    Grossman TH; Anderson MS; Christ D; Gooldy M; Henning LN; Heine HS; Kindt MV; Lin W; Siefkas-Patterson K; Radcliff AK; Tam VH; Sutcliffe JA
    Antimicrob Agents Chemother; 2017 Aug; 61(8):. PubMed ID: 28559261
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Formulation and efficacy of liposome-encapsulated antibiotics for therapy of intracellular Mycobacterium avium infection.
    Oh YK; Nix DE; Straubinger RM
    Antimicrob Agents Chemother; 1995 Sep; 39(9):2104-11. PubMed ID: 8540724
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intranasal interleukin-12 treatment promotes antimicrobial clearance and survival in pulmonary Francisella tularensis subsp. novicida infection.
    Pammit MA; Budhavarapu VN; Raulie EK; Klose KE; Teale JM; Arulanandam BP
    Antimicrob Agents Chemother; 2004 Dec; 48(12):4513-9. PubMed ID: 15561819
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.